Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trialMale circumcision for HIV prevention: current research and programmatic issuesFacilitators of adherence to the study pill in the FEM-PrEP clinical trialPrevalence and Correlates of HIV Infection among Street Boys in Kisumu, KenyaEffect of providing conditional economic compensation on uptake of voluntary medical male circumcision in Kenya: a randomized clinical trialDeterminants of consistent condom use vary by partner type among young men in Kisumu, Kenya: a multi-level data analysis.Is male circumcision as good as the HIV vaccine we've been waiting for?Surgical efficiencies and quality in the performance of voluntary medical male circumcision (VMMC) procedures in Kenya, South Africa, Tanzania, and Zimbabwe.Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.Risk of HIV acquisition among circumcised and uncircumcised young men with penile human papillomavirus infection.Widow cleansing and inheritance among the Luo in Kenya: the need for additional women-centred HIV prevention optionsPromoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort studyIncreased risk of HIV acquisition among Kenyan men with human papillomavirus infection.Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: lessons learned during the first yearAbundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men.Spatial distribution and cluster analysis of sexual risk behaviors reported by young men in Kisumu, Kenya.Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program.HPV vaccine acceptability among Kenyan women.Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, KenyaVoluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011.A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South AfricaScaling sexual behavior or "sexual risk propensity" among men at risk for HIV in Kisumu, Kenya.Safety of over twelve hundred infant male circumcisions using the Mogen clamp in Kenya.HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections.Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya.Circumcision and reduced risk of self-reported penile coital injuries: results from a randomized controlled trial in Kisumu, Kenya.Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, KenyaAccuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials.Multiple human papillomavirus infections and type competition in menPreparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEPEvidence of injection drug use in Kisumu, Kenya: Implications for HIV preventionMale circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.Factors associated with the safety of voluntary medical male circumcision in Nyanza province, KenyaA qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men.Guidance for Providing Informed-Choice Counseling on Sexual Health for Women Interested in Pre-Exposure Prophylaxis in Kenya and South Africa.An ethnographic exploration of drug markets in Kisumu, Kenya
P50
Q21144296-C5DFA492-3B2A-4B0A-B701-CBFD97248A84Q28297402-46E97AD6-C56C-4F60-90D3-206477D7AD08Q28546083-4A9BD9A6-4A29-4AC5-9B04-A2D79741ECEEQ28550213-0B217141-AFAF-40C4-99EA-994C61803E87Q30608628-C41AFEEF-58E8-4C71-9163-A35673BE698AQ33369433-9817F7F1-FB4D-4362-B574-78A6AFF6803FQ33570462-E49938DC-7DB4-49ED-B97B-AE4859FFEC1DQ33573440-78EC8839-F0BF-46C6-A53E-3CE3EFCE9D8CQ33733039-0F53501A-145E-43A4-871C-6588DFF29480Q33762990-90942D4D-B15D-43BE-851D-343B78B91E1FQ33817963-2F556117-4D0E-40F5-92F3-A010C069DE1FQ33818474-B80A115C-53FD-4A37-87F3-97F1D9893794Q33847228-813ADFC8-5A4A-4C51-8EF3-96A318028F18Q33865960-D31775EB-F738-42CA-BE45-E64D97E4C744Q33869298-44B6E0EF-2B63-4F44-91FE-914F3931357AQ33882463-57CDE287-C99F-40AE-B838-A1AFFF846279Q33898411-C7BCC181-4931-4FEB-BA66-10CFA9139C5CQ33908486-09B81A6E-BB4E-4BA4-BE21-40EA300C899AQ34005291-B425127D-6D73-4CAB-BB3C-3BAD4D0F7733Q34013600-FDC6235E-6009-439F-8BCB-F14C3AABCB0BQ34090900-82C88125-38ED-4A2A-B821-2FC2040E619EQ34180749-CD1C3013-D969-467D-88C4-3A1ED2733CEDQ34205161-084481C5-6532-44D5-A3B2-C53ACA875373Q34395510-020FECB3-CC14-4547-B16F-0A86CDA223D4Q34452099-F111DFD7-C6B4-4A39-9244-11B8EB84C16CQ34513598-FA83618D-AEAA-4564-A9E9-E4C8B2C7D0AFQ34846815-C394E114-A205-40F9-A463-8EFFC70C532EQ34960331-9F0AC273-9BA9-4100-9208-61909603BE77Q35474263-B2F0295A-2937-447C-A79D-37C5C579CF0AQ35558205-06207EC4-A735-4C20-9C2F-FF27B902F4F5Q35623752-8E425BA9-C04E-4801-9F80-3061CFAB4C0CQ35657813-2C56D7BD-85B8-4EB4-913F-E860C5D7ADC5Q35661152-EF4691DA-75B0-4EAE-AE58-9CD2E9C793EDQ35683093-96B1781D-B780-49E2-AD3D-0875BFC86D84Q36006842-E271B038-A037-4A2F-B040-BA60490725A2Q36316522-64D23FA5-7C9E-497D-B08E-64D41E771D14Q36324004-45AF4A55-0291-464F-A998-E4C470F14849Q36379269-B6E2E083-6AC0-46A4-8E01-E4DE19F4F33FQ36661468-55AEA2BC-8202-4789-AA77-E6E0261A609CQ36837365-EA96690D-E6CA-46C4-9BFC-ACFDE2A95089
P50
description
medical researcher
@en
onderzoekster uit Kenia
@nl
vénérologue kényane
@fr
name
Kawango Agot
@ast
Kawango Agot
@en
Kawango Agot
@es
Kawango Agot
@fr
Kawango Agot
@nl
Kawango Agot
@sl
type
label
Kawango Agot
@ast
Kawango Agot
@en
Kawango Agot
@es
Kawango Agot
@fr
Kawango Agot
@nl
Kawango Agot
@sl
altLabel
E. Kawango Agot
@fr
prefLabel
Kawango Agot
@ast
Kawango Agot
@en
Kawango Agot
@es
Kawango Agot
@fr
Kawango Agot
@nl
Kawango Agot
@sl
P214
P101
P106
P21
P213
0000 0000 4176 8260
0000 0001 3795 3647
P214
P27
P31
P7859
lccn-no2002014459